Medicated Agent: Lopressor

Active Ingredient Composition

Lopressor’s primary active component is metoprolol tartrate. This agent functions as a selective beta-1-adrenergic receptor blocker.

Formulations Available

Lopressor is available in oral tablet formulations commonly found in strengths of 50 mg and 100 mg. Injectable formulations of metoprolol tartrate are also available for acute interventions.

Mechanism of Action

Lopressor works by blocking beta-1 adrenergic receptors in the heart. This leads to a reduction in heart rate, cardiac output, and the force of heart contractions. Consequently, this reduces myocardial oxygen demand.

Primary Indications

Lopressor is indicated for managing hypertension, angina pectoris, and post-myocardial infarction management. It is also used off-label for conditions such as migraine prophylaxis and essential tremor.

Administration Guidelines

Oral Lopressor tablets should be taken with or immediately following meals for optimal absorption. The dosage must be tailored according to the specific medical condition and response to treatment. Injectable Lopressor is typically administered in hospital settings under careful monitoring.

Dosage Range

The standard initial oral dose for hypertension typically starts at 100 mg daily, which can be split into two doses. For angina, the initial dosage is often 100-150 mg per day, administered in divided doses. Adjustments are made based on patient’s response and tolerance.

Pharmacokinetics Details

Lopressor is absorbed from the gastrointestinal tract, with peak plasma concentrations occurring approximately 1.5 to 2 hours post-ingestion. The bioavailability is around 50%, and the drug is subject to significant first-pass metabolism in the liver. Its half-life ranges from 3 to 7 hours.

Common Adverse Reactions

Patients may experience fatigue, dizziness, and depressive symptoms. Less commonly, gastrointestinal disturbances such as nausea, vomiting, and diarrhea may occur. Cold extremities and bradycardia are also reported.

Serious Adverse Effects

Bradycardia, heart block, and heart failure are critical adverse reactions. Respiratory distress can occur, especially in patients with preexisting pulmonary conditions. Immediate medical intervention may be required for any severe reactions.

Contraindications Info

Lopressor is contraindicated in patients with bradycardia, heart block greater than first-degree, cardiogenic shock, overt cardiac failure, and in those with hypersensitivity to metoprolol or any component of the product.

Drug Interaction Profile

Lopressor may interact with other antihypertensives, leading to additive effects. It is metabolized by the cytochrome P450 2D6 pathway and may interact with drugs that induce or inhibit this enzyme. Significant interactions include those with calcium channel blockers and digitalis glycosides.

Special Populations Notes

Renal impairment often does not necessitate dosage adjustment. However, caution is advised in patients with hepatic impairment due to the drug’s significant first-pass metabolism. Elderly patients may be more sensitive to metoprolol’s effects.

Pregnancy and Lactation

Metoprolol crosses the placental barrier and is excreted in breast milk. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Caution is advised if administering to breastfeeding women.

Storage Instructions

Lopressor tablets should be stored at controlled room temperature and protected from moisture. Injectable forms should be kept away from light, and storage conditions should adhere to standards defined in their specific product labeling.

Secondary Indications

In addition to its primary uses, Lopressor may be prescribed off-label for conditions such as anxiety management and prevention of variceal bleeding in cirrhosis. These secondary indications are based on clinical judgment and patient-specific factors.

Patient Monitoring Requirements

Patients on Lopressor should have regular monitoring of blood pressure and heart rate. ECG monitoring may be necessary for patients with suspected arrhythmias. Liver function tests may be required periodically in long-term use cases.

Adjustments in Chronic Conditions

Dosages need modification when transitioning chronic conditions such as heart failure. Adjustments should follow a titration schedule to avoid exacerbation of symptoms or adverse reactions.

Missed Dose Instructions

If a dose is missed, it should be taken as soon as remembered, unless it is nearly time for the next dose. Doubling up on doses to make up for a missed dose is not recommended.

Overdose Management

In the event of an overdose, symptomatic treatment is essential. Hemodialysis is not effective in removing Lopressor from the body due to its extensive tissue binding. Intensive monitoring and supportive measures are crucial.